Anti-conflict efficacy of buspirone following acute versus chronic treatment.
In many animal studies, acute treatment with the novel anxiolytic agent buspirone exhibits only minimal "anxiolytic efficacy" (i.e., increases in punished responding) when compared to benzodiazepines and barbiturates. The present studies examined the effects of acute pre-test challenges with buspirone in subjects receiving chronic post-test buspirone or saline treatments. Chronic post-test treatment with buspirone (4 mg/kg/day for 4 weeks, followed by 8 mg/kg/day for 12 weeks) did not significantly affect CSD behavior. Consistent with previous reports, acute pre-test administration of buspirone (0.125-2 mg/kg, IP) to subjects receiving chronic post-test saline treatment resulted in only a modest anti-conflict effect in the CSD paradigm (approximately ten shocks over control). In contrast, subjects chronically treated with buspirone exhibited a dramatically greater anti-conflict effect following acute challenge with buspirone (up to 40 shocks over control). These data are consistent with the hypothesis that the full anxiolytic efficacy of buspirone requires repeated administration.
Schefke
D M
DM
Department of Pharmaceutical Sciences, College of Pharmacy, Wayne State University, Detroit, MI 48202.
Fontana
D J
DJ
Commissaris
R L
RL
D000818:Animals; D001522:Behavior, Animal / Q000187:drug effects*; D002065:Buspirone / Q000494:pharmacology*; D003220:Conflict, Psychological; D005260:Female; D051381:Rats; D011919:Rats, Inbred Strains
D002065:Buspirone